Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 417,116 $ 955,563
Short-term investments 803,712 343,248
Total cash, cash equivalents and short-term investments 1,220,828 1,298,811
Other receivables 2,722 2,315
Prepaid expenses and other current assets 19,055 17,416
Total current assets 1,242,605 1,318,542
Property and equipment, net 57,920 53,155
Restricted cash 1,731 762
Equity method investment 27,006 20,306
Intangible assets 14,529 14,512
Goodwill 10,757 10,757
Other non-current assets 68,747 70,321
Total assets 1,423,295 1,488,355
Current liabilities:    
Accounts payable 2,665 3,637
Accrued and other current liabilities 15,498 10,211
Total current liabilities 18,163 13,848
Stock repurchase liability 589 711
Warrant Liability 47,493 44,902
Earnout Shares Liability 90,440 109,844
Other non-current liabilities 2,176 2,291
Total liabilities 158,861 171,596
Commitments and contingencies (Note 7)
Stockholders' equity:    
Preferred stock: $0.0001 par value - 100,000,000 shares and 100,000,000 shares authorized at March 31, 2022 and December 31, 2021, respectively. No shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively. 0 0
Common stock: $0.0001 par value - 1,400,000,000 and 1,400,000,000 shares authorized, [XXX] and 604,174,329 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively. 60 60
Additional paid-in capital 1,805,983 1,793,431
Accumulated deficit (538,929) (476,610)
Accumulated other comprehensive income (2,680) (122)
Total stockholders' equity 1,264,434 1,316,759
Total liabilities and stockholders' equity $ 1,423,295 $ 1,488,355